A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

GS-3242 TabletOngoingRecruitingPhase 2Open NCT07645287 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07645287 · Trial Tracker · ComplyRx